Hopman Mark sold BBNX
August 19, 2025 · Form 4 insider transaction
Hopman Mark sold 16,158 shares of Beta Bionics, Inc. at $16.61 per share, a transaction worth $268.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
16,158
Price
$16.61
Total value
$268.4K
InsiderHopman Mark
RoleOfficer
CompanyBeta Bionics, Inc. (BBNX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 19, 2025
Filing dateAugust 20, 2025
Shares owned after34,132
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025.; The weighted average sale price for the transaction reported was $16.6095 and the range of prices were between $16.26 and $17.1719. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.